<< Back
JMP Group Announces Addition of Liisa A. Bayko as Senior Healthcare Research Analyst

SAN FRANCISCO, Oct 02, 2007 (BUSINESS WIRE) -- JMP Group Inc. (NYSE:JMP), a growth-oriented investment banking and asset management firm, announced today that Liisa A. Bayko has joined JMP Securities, JMP Group's broker-dealer subsidiary, as a director and senior research analyst covering the biotechnology industry.

"We are very pleased to welcome Liisa Bayko to JMP," said Mark Lehmann, JMP Securities' co-president and director of equities. "Liisa brings tremendous experience in the biotechnology arena--as a sell-side analyst, as a buy-side investor and as an industry professional. Liisa's coverage of the sector will expand JMP's existing biotechnology research effort, enabling us to provide even more insight and actionable information to the institutional brokerage clients who turn to JMP Securities for perspective on the healthcare industry."

Prior to joining JMP Securities, Bayko was a director and senior biotechnology analyst at Next Generation Equity Research. She previously served as an equity research associate at Prudential Equity Group and worked as a research analyst at Baker Brothers Investments, a biotechnology-focused asset management firm. She began her career at Pharmacia Corporation as a senior analyst in the strategy development group. Bayko holds an MBA from the Kellogg School of Management at Northwestern University, a Master of Science degree in medical biophysics from the University of Toronto and a Bachelor of Science degree with honors from Queen's University in Kingston, Canada.

About JMP Group

JMP Group Inc. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and alternative asset management products to institutional and high-net-worth investors. JMP Group operates through two subsidiaries, JMP Securities LLC and JMP Asset Management LLC. For more information, visit www.jmpg.com.

SOURCE: JMP Group Inc.

KCSA Worldwide
Jeffrey Goldberger, 212-896-1249 (Investor Relations)
JMP Group
Andrew Palmer, 415-835-8978 (Press)

Copyright Business Wire 2007

News Provided by COMTEX